Related Experiment Video
Updated: Nov 29, 2025
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing? : A Systematic Review
Aaron P Mitchell1, Niti U Trivedi1, Renee L Gennarelli1
1Memorial Sloan Kettering Cancer Center, New York, New York (A.P.M., N.U.T., R.L.G., S.C., S.M.T., L.A.D., D.K.).
Background:
Financial payments from the drug industry to U.S. physicians are common. Payments may influence physicians' clinical decision making and drug prescribing.
Purpose:
To evaluate whether receipt of payments from the drug industry is associated with physician prescribing practices.
Data Sources:
MEDLINE (Ovid), Embase, the Cochrane Library, Web of Science, and EconLit were searched without language restrictions. The search had no limiting start date and concluded on 16 September 2020.
Study Selection:
Studies that estimated the association between receipt of industry payments (exposure) and prescribing (outcome).
Data Extraction:
Pairs of reviewers extracted the primary analysis or analyses from each study and evaluated risk of bias (ROB).
Data Synthesis:
Thirty-six studies comprising 101 analyses were included. Most studies (n = 30) identified a positive association between payments and prescribing in all analyses; the remainder (n = 6) had a mix of positive and null findings. No study had only null findings. Of 101 individual analyses, 89 identified a positive association. Payments were associated with increased prescribing of the paying company's drug, increased prescribing costs, and increased prescribing of branded drugs. Nine studies assessed and found evidence of a temporal association; 25 assessed and found evidence of a dose-response relationship.
Limitation:
The design was observational, 21 of 36 studies had serious ROB, and publication bias was possible.
Conclusion:
The association between industry payments and physician prescribing was consistent across all studies that have evaluated this association. Findings regarding a temporal association and dose-response suggest a causal relationship.
Primary Funding Source:
National Cancer Institute.
Related Concept Videos
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:02Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:15Drug Abuse and Addiction: Pharmacological Phenomena
01:30Quantitative Aspects of Drug-Receptor Interaction
01:03Dose-Response Relationship: Overview